FDG-PET/CT in lymphoma
| Autor: | Rajendra Prashad Tripathi, Abhinav Jaimini, Anupam Mondal, Abhishek Bansal, Maria M D'Souza, Rajnish Sharma, Madhavi Tripathi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
PET-CT
medicine.medical_specialty Heterogeneous group medicine.diagnostic_test Imaging lymphoma PET/CT business.industry R895-920 Computed tomography Disease medicine.disease Lymphoma Medical physics. Medical radiology. Nuclear medicine Positron emission tomography immune system diseases hemic and lymphatic diseases medicine Pet-Ct Radiology Nuclear Medicine and imaging Fdg pet ct Radiology business Indolent lymphomas |
| Zdroj: | Indian Journal of Radiology and Imaging, Vol 23, Iss 4, Pp 354-365 (2013) The Indian Journal of Radiology & Imaging Indian Journal of Radiology and Imaging, Vol 23, Iss 04, Pp 354-365 (2013) |
| ISSN: | 1998-3808 0971-3026 |
| Popis: | Lymphomas are a heterogeneous group of diseases that arise from the constituent cells of the immune system or from their precursors. 18F-fludeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) is now the cornerstone of staging procedures in the state-of-the-art management of Hodgkin′s disease and aggressive non-Hodgkin′s lymphoma. It plays an important role in staging, restaging, prognostication, planning appropriate treatment strategies, monitoring therapy, and detecting recurrence. However, its role in indolent lymphomas is still unclear and calls for further investigational trials. The protean PET/CT manifestations of lymphoma necessitate a familiarity with the spectrum of imaging findings to enable accurate diagnosis. A meticulous evaluation of PET/CT findings, an understanding of its role in the management of lymphomas, and knowledge of its limitations are mandatory for the optimal utilization of this technique. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|